⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

VTRS

Viatris Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

18.00USD

-0.4800 (-2.60%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on VTRS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.64▼$0.6412
Next quarter$0.59▼$0.6212
Current year$2.52▲$2.4621
Next year$2.7▲$2.6320

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$0.6$0.69+0.09 (+15.0%)
2026-03-31$0.5$0.59+0.09 (+17.5%)
2025-12-31$0.53$0.57+0.04 (+7.4%)
2025-09-30$0.62$0.67+0.05 (+8.5%)

Wall Street coverage

53 ratings from 17 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
JP MorganMaintainedNeutral$18 $20Oct 21, 2026
UBSMaintainedBuy$23 $26Oct 5, 2026
OppenheimerInitiatedOutperform$25Sep 23, 2026
Piper SandlerMaintainedNeutral$12 $13Sep 16, 2026
Leerink PartnersInitiatedOutperform$20Sep 9, 2026
Argus ResearchMaintainedBuy$15 $20Sep 8, 2026
BarclaysMaintainedOverweight$17 $22May 19, 2026
JP MorganMaintainedNeutral$17 $18May 8, 2026
Truist SecuritiesMaintainedBuy$18 $20May 8, 2026
BarclaysMaintainedOverweight$15 $17Mar 24, 2026
Piper SandlerMaintainedNeutral$9 $12Jan 28, 2026
Argus ResearchUpgraded from HoldBuy$15Jan 16, 2026
BarclaysInitiatedOverweight$15Dec 9, 2025
Truist SecuritiesInitiatedBuy$15Oct 15, 2025
Goldman SachsInitiatedNeutral$10Jun 6, 2025
JefferiesMaintainedBuy$15 $13Mar 7, 2025
Piper SandlerReiteratedNeutral$14 $10Mar 5, 2025
BarclaysMaintainedUnderweight$12 $9Feb 28, 2025
B of A SecuritiesMaintainedUnderperform$11 $10Feb 28, 2025
Piper SandlerReiteratedNeutral$13 $14Dec 6, 2024
BarclaysMaintainedUnderweight$11 $12Nov 8, 2024
Piper SandlerReiteratedNeutral$11 $13Mar 28, 2024
Piper SandlerMaintainedNeutral$10 $11Nov 22, 2023
B of A SecuritiesDowngraded from NeutralUnderperform$9Oct 23, 2023
BarclaysDowngraded from Equal-WeightUnderweight$11Jun 23, 2023

Insider transactions

2 filings from 2 insiders · 1 buy / 1 sell over 6m

Officers and directors of VTRS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Groothuis Leo FransDirectorGrantDeferred Stock Units2.5k$17.72$44kSep 30, 2026
SIMMONS DAVID SDirectorGrantDeferred Stock Units2.1k$17.72$38kSep 30, 2026

Analyst Notes

Sign in to write

No analyst notes on VTRS yet.

Analyst Ratings

10 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current16401Hold2.50
1 mo ago16401Hold2.50
2 mo ago14401Hold2.60
3 mo ago14401Hold2.60
Price target$19.90$13.00 – $26.00
+10.6% to target

Top voices on VTRS

Members whose judged calls on VTRS have played out most reliably.

No settled calls on VTRS yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice